Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Read more
Subcategories of "Inhibitors"
Angiogenesis
Apoptosis
Cell Cycle/Checkpoint
Chromatin/Epigenetics
Cytoskeletal Signaling
DNA Damage/DNA Repair
Endocrinology/Hormones
Enzyme
GPCR/G-Protein
Immunology and Inflammation
Influenza Virus
JAK/STAT signaling
MAPK Signaling
Membrane Transporter/Ion Channel
Metabolism
Microbiology/Virology
Neuroscience
Other Inhibitors
Oxidation-Reduction
PI3K/Akt/mTOR Signaling
Proteases/Proteasome
Stem Cell and Derivatives
Tyrosine Kinase/Adaptors
Ubiquitination
Show 16 more subcategories
Products of "Inhibitors"
SB-224289 hydrochloride
CAS:180084-26-8
SB-224289 hydrochloride (SB-224289A) is a selective antagonist of 5-HT1B receptor, with anxiolytic effect.
Formula:
C32H33ClN4O3
Purity:
97.82% - 98.09%
Color and Shape:
Solid
Molecular weight:
557.08
Ref: TM-T12841
| 5mg | 52.00 € | ||
| 10mg | 89.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 89.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Plevitrexed
CAS:153537-73-6
Plevitrexed, an oral TS inhibitor (Ki: 0.44 nM), targets α-folate receptor & reduced folate carrier, …
Formula:
C26H25FN8O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
532.53
Ref: TM-T12635L
| 25mg | 3,079.00 € | ||
| 50mg | 4,094.00 € | ||
| 100mg | 5,701.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
CV 5975
CAS:100277-62-1
CV 5975 is a nonsulfhydryl ACE inhibitor that was investigated for use in hypertension and …
Formula:
C22H31N3O5S
Color and Shape:
Liquid
Molecular weight:
449.56
Ref: TM-T71644
| 25mg | 2,572.00 € | ||
| 50mg | 3,385.00 € | ||
| 100mg | 4,632.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
SARS-CoV-2 nsp14-IN-1
SARS-CoV-2 nsp14-IN-1 inhibits Nsp14 Mtase with an IC50 of 0.061 μM, affecting multiple substrates.
Formula:
C20H20N6O5S
Color and Shape:
Liquid
Molecular weight:
456.48
Ref: TM-T62829
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
MCTR1
CAS:1784701-61-6
MCTR1, a pro-resolving mediator derived from DHA, promotes tissue repair and reduces inflammation by enhancing …
Formula:
C32H47N3O9S
Color and Shape:
Liquid
Molecular weight:
649.8
Ref: TM-T37505
| 10µg | 369.00 € | ||
| 25µg | 873.00 € | ||
| 50µg | 1,645.00 € | ||
| 100µg | 2,742.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Cathepsin C-IN-5
CAS:2825567-97-1
Cathepsin C-IN-5 (SF38) is a potent, oral Cathepsin C blocker with an IC50 of 59.9 …
Formula:
C21H17ClN6OS
Color and Shape:
Liquid
Molecular weight:
436.92
Ref: TM-T62494
| 25mg | 808.00 € | ||
| 50mg | 1,050.00 € | ||
| 100mg | 1,522.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
PDE4B/7A-IN-1
CAS:2511632-25-8
5-HT1A antagonist; Ki=8nM, Kb=0.04nM. PDE4B IC50=80.4μM; PDE7A IC50=151.3μM. Good biofilm penetration, stable, anticognitive, antidepressant.
Formula:
C25H35N3O3
Color and Shape:
Liquid
Molecular weight:
425.56
Ref: TM-T62303
| 25mg | 1,437.00 € | ||
| 50mg | 1,872.00 € | ||
| 100mg | 2,364.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
SX 3202
CAS:147254-65-7
SX 3202 is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy.
Formula:
C17H11BrFN3O4
Color and Shape:
Liquid
Molecular weight:
420.19
Ref: TM-T70579
| 25mg | 2,288.00 € | ||
| 50mg | 3,006.00 € | ||
| 100mg | 4,065.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
HOIPIN-8 sodium
CAS:2519537-70-1
HOIPIN-8 sodium is a LUBAC inhibitor for the study of inflammatory and immune diseases.
Formula:
C23H15F2N4NaO3
Color and Shape:
Liquid
Molecular weight:
456.38
Ref: TM-T62826
| 1mg | 113.00 € | ||
| 5mg | 269.00 € | ||
| 10mg | 461.00 € | ||
| 25mg | 884.00 € | ||
| 50mg | 1,383.00 € | ||
| 100mg | 2,190.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Sdz 210-096
CAS:109026-86-0
Sdz 210-096: a 14 beta-benzyl morphinan, mu/kappa opiate receptor antagonist, stimulates LH secretion in rats.
Formula:
C27H31NO2
Color and Shape:
Liquid
Molecular weight:
401.54
Ref: TM-T71466
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 11 Mar 2025
KRAS G12C inhibitor 50
CAS:2760354-12-7
KRAS G12C inhibitor 50 is a KRAS G12C inhibitor (IC50: 46.7 nM).
Formula:
C31H34N8O2
Color and Shape:
Liquid
Molecular weight:
550.65
Ref: TM-T63891
| 25mg | 1,951.00 € | ||
| 50mg | 2,539.00 € | ||
| 100mg | 3,209.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Antileishmanial agent-4
Antileishmanial agent-4, a ribonucleoside analogue, functions as an antileishmanial agent [1].
Formula:
C17H18N4O4
Color and Shape:
Liquid
Molecular weight:
342.35
Ref: TM-T61100
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
GSK-3β inhibitor 6
GSK-3β inhibitor 6 is a highly potent inhibitor of GSK-3β, with an IC50 value of …
Formula:
C20H17BrN4
Color and Shape:
Liquid
Molecular weight:
393.28
Ref: TM-T61804
| 25mg | 1,437.00 € | ||
| 50mg | 1,872.00 € | ||
| 100mg | 2,364.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
NTPDase-IN-3
CAS:2883147-45-1
NTPDase-IN-3 inhibits NTPDase1/2/3/8 (IC50: 0.21/1.07/0.38/0.05 μM), useful for cancer and thrombosis research.
Formula:
C22H24ClN3OS2
Color and Shape:
Liquid
Molecular weight:
446.03
Ref: TM-T62633
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Tilpisertib fosmecarbil
CAS:2567459-64-5
Tilpisertib fosmecarbil is a potent inhibitor of serine/threonine kinases with anti-inflammatory properties.
Formula:
C35H36ClN8O7P
Color and Shape:
Liquid
Molecular weight:
747.14
Ref: TM-T72292
| 25mg | 2,890.00 € | ||
| 50mg | 3,811.00 € | ||
| 100mg | 5,288.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Tetrahydrouridine dihydrate
THU dihydrate, a potent CDA inhibitor, outperforms cytidine by blocking the enzyme's active site.
Formula:
C9H20N2O8
Color and Shape:
Liquid
Molecular weight:
284.26
Ref: TM-T60553
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Menin-MLL inhibitor 26
CAS:2440018-29-9
Menin-MLL inhibitor 26: Active reference, inhibits cell growth, used in leukemia research.
Formula:
C27H29F3N6O3S
Color and Shape:
Liquid
Molecular weight:
574.62
Ref: TM-T72360
| 25mg | 3,027.00 € | ||
| 50mg | 3,993.00 € | ||
| 100mg | 5,561.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
AHR antagonist 5 hemimaleate
Potent oral AHR antagonist with IC50 < 0.5 μM, hinders tumor growth with anti-PD-1.
Formula:
C29H28FN7O4
Color and Shape:
Liquid
Molecular weight:
499.55
Ref: TM-T63389
| 25mg | 1,437.00 € | ||
| 50mg | 1,872.00 € | ||
| 100mg | 2,364.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
PCSK9-IN-16
CAS:2455424-51-6
PCSK9-IN-16, holds potential for research into hypercholesterolemia and other cardiovascular diseases [1].
Formula:
C16H20N6O2S3
Color and Shape:
Liquid
Molecular weight:
424.56
Ref: TM-T79052
| 25mg | 2,288.00 € | ||
| 50mg | 3,006.00 € | ||
| 100mg | 4,065.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
Tamitinol
CAS:61711-37-3
Tamitinol is a neurotropic drug. It has been found to help symptoms of obsessive rumination …
Formula:
C12H20N2OS
Purity:
98%
Color and Shape:
Solid
Molecular weight:
240.37
Ref: TM-T24852
| 25mg | 2,245.00 € | ||
| 50mg | 2,972.00 € | ||
| 100mg | 4,019.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
